Q2 2017 13F Holders as of 6/30/2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
12.7M
-
Number of holders
-
32
-
Total 13F shares, excl. options
-
1.5M
-
Shares change
-
-294K
-
Total reported value, excl. options
-
$12.9M
-
Value change
-
-$2.64M
-
Number of buys
-
16
-
Number of sells
-
-28
-
Price
-
$8.59
Significant Holders of IRADIMED CORP - Common Stock (IRMD) as of Q2 2017
47 filings reported holding IRMD - IRADIMED CORP - Common Stock as of Q2 2017.
IRADIMED CORP - Common Stock (IRMD) has 32 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.5M shares
of 12.7M outstanding shares and own 11.79% of the company stock.
Largest 10 shareholders include AMERIPRISE FINANCIAL INC (344K shares), Mondrian Investment Partners LTD (207K shares), VANGUARD GROUP INC (181K shares), AQR CAPITAL MANAGEMENT LLC (147K shares), Granite Investment Partners, LLC (112K shares), MENTA CAPITAL LLC (70.5K shares), Spark Investment Management LLC (66.9K shares), OxFORD Asset Management LLP (51.3K shares), BlackRock Inc. (42.7K shares), and FEDERATED INVESTORS INC /PA/ (40.4K shares).
This table shows the top 32 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.